Search / 380 results found

from
to
  • Updated

SEATTLE, Nov. 30, 2021 /PRNewswire-PRWeb/ -- As the demand for fast, reliable self-tests for COVID-19 antigen remains high, InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) allowing the company to market its SCoV-2 Ag Detect Rapid Self-Test, a three-step home use antigen test for COVID-19 that provides results in ~20 minutes.

  • Updated

SEATTLE, Nov. 18, 2021 /PRNewswire/ -- Five patients with mild to moderate dementia received a proprietaryintranasal dual gene therapy composed of hTERT and Klotho. The treatment demonstrated an excellent safety profile with no complications. Efficacy data was also collected and tracked, including cognitive testing, immune system response, physical exams, telomere length, blood analyses, and brain imaging.

  • Updated
  • 6 min to read

Shelly Lawrence distinctly remembers Monday, Sept. 7, 2020. It was Labor Day, and she was excited to spend time with her family. While getting out of bed, Lawrence remembers her hand brushing the area by her left breast and feeling a large bump.

  • Updated

Priorities— Lawrence said it is important to give yourself grace and to feel any emotions that come up, especially after being diagnosed with …